For research and educational purposes only. Not medical advice.
Huperzine A Reference
Educational, not medical advice reference for Huperzine A: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Chinese clinical literature in Alzheimer's disease and cognitive impairment. Western Phase 2 data did not yield FDA approval.
- Categories
- Nootropic, Cognitive
- Aliases
- Huperzia serrata extract, AChE inhibitor
- Evidence posture
- human — Sold as a dietary supplement, not as an FDA-approved drug. Acetylcholinesterase inhibitor — concomitant cholinergic drugs (donepezil, etc.) can produce additive cholinergic effects. Not a treatment.
- Regulatory status
- No FDA-approved huperzine A drug label. Sold as a dietary supplement; investigated for Alzheimer's disease with mixed results.
- Content review status
- research reference